Literature DB >> 21652168

Influenza myocarditis and myositis: case presentation and review of the literature.

Kanwal Kumar1, Mina Guirgis, Shelley Zieroth, Evelyn Lo, Alan H Menkis, Rakesh C Arora, Darren H Freed.   

Abstract

Myocarditis, a general inflammatory condition of the heart muscle, can result from a variety of etiologies, the most common being viral. Despite common pathogens, concomitant myocarditis and myositis remains a rare event. Although a common cause of respiratory illness, extrapulmonary infections with influenza are infrequent. We describe the case of a patient who presented to our centre with concomitant "seasonal" H1N1 influenza A myocarditis further complicated by pan-myositis. The patient's condition rapidly declined, eventually requiring biventricular mechanical support, in addition to multilimb fasciotomies. The cardiac support required was progressive, from a percutaneous left ventricular assist device, to extracorporeal membrane oxygenation, to eventual biventricular assist device support for bridge-to-transplantation. This case motivated a detailed review of the literature (a total of 29 cases were identified), in which we found that patients with influenza myocarditis/myositis were predominantly female (63%) and young (mean age 33.2 years) and continue to have a high incidence of morbidity and mortality (27%). As a result of its atypical pattern, the 2009 H1N1 pandemic strain has gained attention. From our review, we found 7 patients with of 2009 H1N1 pandemic influenza myocarditis. Serial serum cytokine analysis did not demonstrate a "cytokine storm," which has been associated with other virulent influenza strains. The PB1-F2 marker in particular has been associated with a vigorous cytokine response. The 2009 H1N1 and "seasonal" influenza strains lack this marker. In those patients with community-acquired influenza, interleukin-6 has been shown to correlate with symptoms. For patients with myocarditis resulting in shock, mechanical circulatory support has gained acceptance as a means to recovery or transplantation.
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21652168     DOI: 10.1016/j.cjca.2011.03.005

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  35 in total

1.  Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.

Authors:  Bárbara Borgatta; Marcos Pérez; J Rello; Loreto Vidaur; Leonardo Lorente; Lorenzo Socías; Juan Carlos Pozo; J C Pozo; José Garnacho-Montero; Jordi Rello
Journal:  Intensive Care Med       Date:  2012-04-18       Impact factor: 17.440

2.  Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.

Authors:  Chiharu Kishimoto; Keisuke Shioji; Tetsuo Hashimoto; Hiroshi Nonogi; Jong-Dae Lee; Shigeru Kato; Shinya Hiramitsu; Shin-ihiro Morimoto
Journal:  Heart Vessels       Date:  2013-05-24       Impact factor: 2.037

3.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

4.  Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity.

Authors:  Nicolas Martinez-Calle; Paula Rodriguez-Otero; Sara Villar; Luis Mejías; Ignacio Melero; Felipe Prosper; Patricia Marinello; Bruno Paiva; Miguel Idoate; Jesus San-Miguel
Journal:  Haematologica       Date:  2018-04-12       Impact factor: 9.941

5.  Atypical clinic presentation of pandemic influenza A successfully rescued by extracorporeal membrane oxygenation - Our experience and review of the literature.

Authors:  Massimo Bonacchi; Marco Ciapetti; Gabriella Di Lascio; Guy Harmelin; Guido Sani; Adriano Peris
Journal:  Interv Med Appl Sci       Date:  2013-12-20

Review 6.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.

Authors:  Katharina Karsch; Xi Chen; Oliver Miera; Björn Peters; Patrick Obermeier; Roland C Francis; Válerie Amann; Susanne Duwe; Pieter Fraaij; Alla Heider; Marcel de Zwart; Felix Berger; Albert Osterhaus; Brunhilde Schweiger; Barbara Rath
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

Review 8.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

9.  Biopsy detection and clinical management of acute lymphocytic myocarditis in pregnancy.

Authors:  Daisuke Sunohara; Hirohiko Motoki; Tatsuya Saigusa; Soichiro Ebisawa; Ayako Okada; Hirofumi Ando; Midori Sato; Koichiro Kuwahara
Journal:  J Cardiol Cases       Date:  2019-08-12

Review 10.  New treatments for influenza.

Authors:  Sailen Barik
Journal:  BMC Med       Date:  2012-09-13       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.